Dasnib Description

DASNIB 20 mg film-coated tablets: White to off-white, biconvex, round film-coated tablet with a diameter of approximately 6 mm, with D7SB debossed on one side and 20 on the other side.
Each film-coated tablet contains 20 mg dasatinib (as monohydrate).
DASNIB 50 mg film-coated tablets: White to off-white, biconvex, oval film-coated tablet with a length of approximately 11 mm and a width of approximately 6 mm, with D7SB debossed on one side and 50 on the other side.
Each film-coated tablet contains 50 mg dasatinib (as monohydrate).
DASNIB 70 mg film-coated tablets: White to off-white, biconvex, round film-coated tablet with a diameter of approximately 9 mm, with D7SB debossed on one side and 70 on the other side.
Each film-coated tablet contains 70 mg dasatinib (as monohydrate).
DASNIB 80 mg film-coated tablets: White to off-white, biconvex, triangular film-coated tablet with a length of approximately 10 mm and a width of approximately 11 mm, with D7SB debossed one side and 80 on the other side.
Each film-coated tablet contains 80 mg dasatinib (as monohydrate).
DASNIB 100 mg film-coated tablets: White to off-white, biconvex, oval film-coated tablet with a length of approximately 15 mm and a width of approximately 7 mm, with D7SB debossed on one side and 100 on the other side.
Each film-coated tablet contains 100 mg dasatinib (as monohydrate).
DASNIB 140 mg film-coated tablets: White to off-white, biconvex, round film-coated tablet with a diameter of approximately 12 mm, with D7SB debossed on one side and 140 on the other side.
Each film-coated tablet contains 140 mg dasatinib (as monohydrate).
Excipients/Inactive Ingredients: Tablet core: Lactose monohydrate, Microcrystalline cellulose, Croscarmellose sodium, Hydroxypropylcellulose, Magnesium stearate.
Film-coating: Hypromellose, Lactose monohydrate, Titanium dioxide (E171), Triacetin.